Portuguese pharmaceutical group FHC will use its acquisition of Activo Health to build its African footprint, beginning with a push into South Africa’s sterile injectables market, senior executives said yesterday. The privately held group bought Activo Health from JSE-listed Afrocentric. FHC owns Laboratórios Basi, a drugmaker based in Mortágua, Portugal, which reported turnover of about €543m (roughly R10bn) in 2025.…
Tag: sterile injectables
-
Aspen secures licensing agreement to enter GLP-1 market
Aspen Pharmacare’s CEO, Stephen Saad, has celebrated the company’s new licensing agreement to enter the rapidly expanding GLP-1 agonist market. He said this milestone marks a “significant coup” for the company, enabling it to prepare for the market by 2026 and capitalise on the anticipated demand for diabetes and obesity treatment solutions. The global GLP-1 market, driven by increased demand…